临床神经病学杂志
臨床神經病學雜誌
림상신경병학잡지
JOURNAL OF CLINICAL NEUROLOGY
2014年
3期
216-218
,共3页
缺血性脑卒中%类肝素药物治疗急性缺血性脑卒中试验亚型分类%糖代谢异常
缺血性腦卒中%類肝素藥物治療急性缺血性腦卒中試驗亞型分類%糖代謝異常
결혈성뇌졸중%류간소약물치료급성결혈성뇌졸중시험아형분류%당대사이상
cerebral ischemic stroke%the Trial of ORG 10172 in acute stroke treatment classification%abnormal glucose metabolism
目的:研究急性缺血性脑卒中患者新诊断的糖代谢异常的影响因素。方法120例无糖尿病史的急性缺血性脑卒中患者按类肝素药物治疗急性缺血性脑卒中试验( TOAST)亚型分类标准,分为大动脉粥样硬化性卒中( LAA)、小动脉闭塞性卒中( SAO)、心源性栓塞( CES)和不明原因的缺血性卒中( UND)亚组。在发病1周后,给患者进行葡萄糖耐量试验( OGTT),出现糖调节受损( IGR)或糖尿病为糖代谢异常。并对有关指标进行比较,以及行多因素Logistic分析。结果本组患者中糖代谢正常68例(56.7%),糖代谢异常52例(43.3%),其中IGR 38例(31.7%)、糖尿病14例(11.7%)。 LAA亚组糖代谢异常的比率(63.8%)明显高于其他亚组(27.3%~31.4%)(均P<0.05);其他亚组间的差异无统计学意义。糖代谢异常组的年龄及高脂血症和有糖尿病家族史的比率明显高于糖代谢正常组( P<0.05~0.01)。多因素Logistic分析示,高脂血症( OR=1.671,95%CI:1.208~2.311,P=0.012)、糖尿病家族史( OR=1.421,95%CI:1.114~1.813, P=0.042)和LAA型(OR=2.825,95%CI:1.706-4.674,P=0.023)是缺血性脑卒中新诊断糖代谢异常的独立危险因素。结论急性缺血性脑卒中患者的新诊断糖代谢异常率较高,高脂血症、糖尿病家族史及LAA亚型是其独立危险因素。
目的:研究急性缺血性腦卒中患者新診斷的糖代謝異常的影響因素。方法120例無糖尿病史的急性缺血性腦卒中患者按類肝素藥物治療急性缺血性腦卒中試驗( TOAST)亞型分類標準,分為大動脈粥樣硬化性卒中( LAA)、小動脈閉塞性卒中( SAO)、心源性栓塞( CES)和不明原因的缺血性卒中( UND)亞組。在髮病1週後,給患者進行葡萄糖耐量試驗( OGTT),齣現糖調節受損( IGR)或糖尿病為糖代謝異常。併對有關指標進行比較,以及行多因素Logistic分析。結果本組患者中糖代謝正常68例(56.7%),糖代謝異常52例(43.3%),其中IGR 38例(31.7%)、糖尿病14例(11.7%)。 LAA亞組糖代謝異常的比率(63.8%)明顯高于其他亞組(27.3%~31.4%)(均P<0.05);其他亞組間的差異無統計學意義。糖代謝異常組的年齡及高脂血癥和有糖尿病傢族史的比率明顯高于糖代謝正常組( P<0.05~0.01)。多因素Logistic分析示,高脂血癥( OR=1.671,95%CI:1.208~2.311,P=0.012)、糖尿病傢族史( OR=1.421,95%CI:1.114~1.813, P=0.042)和LAA型(OR=2.825,95%CI:1.706-4.674,P=0.023)是缺血性腦卒中新診斷糖代謝異常的獨立危險因素。結論急性缺血性腦卒中患者的新診斷糖代謝異常率較高,高脂血癥、糖尿病傢族史及LAA亞型是其獨立危險因素。
목적:연구급성결혈성뇌졸중환자신진단적당대사이상적영향인소。방법120례무당뇨병사적급성결혈성뇌졸중환자안류간소약물치료급성결혈성뇌졸중시험( TOAST)아형분류표준,분위대동맥죽양경화성졸중( LAA)、소동맥폐새성졸중( SAO)、심원성전새( CES)화불명원인적결혈성졸중( UND)아조。재발병1주후,급환자진행포도당내량시험( OGTT),출현당조절수손( IGR)혹당뇨병위당대사이상。병대유관지표진행비교,이급행다인소Logistic분석。결과본조환자중당대사정상68례(56.7%),당대사이상52례(43.3%),기중IGR 38례(31.7%)、당뇨병14례(11.7%)。 LAA아조당대사이상적비솔(63.8%)명현고우기타아조(27.3%~31.4%)(균P<0.05);기타아조간적차이무통계학의의。당대사이상조적년령급고지혈증화유당뇨병가족사적비솔명현고우당대사정상조( P<0.05~0.01)。다인소Logistic분석시,고지혈증( OR=1.671,95%CI:1.208~2.311,P=0.012)、당뇨병가족사( OR=1.421,95%CI:1.114~1.813, P=0.042)화LAA형(OR=2.825,95%CI:1.706-4.674,P=0.023)시결혈성뇌졸중신진단당대사이상적독립위험인소。결론급성결혈성뇌졸중환자적신진단당대사이상솔교고,고지혈증、당뇨병가족사급LAA아형시기독립위험인소。
Objective To investigate the influnce factors of new diagnosed abnormal glucose metabolism in patients with acute cerebral ischemic stroke .Methods One hundres and twenty stroke patients without history of diabetes were divide into large artery atherosclerotic stroke (LAA), small arterial occlusive stroke(SAO), cardiac embolic stroke(CES), undeterminined etiology stroke (UND) subgroups according to the Trial of ORG 10172 in Acute Stroke Treatment(TOAST) classfication.The patients were tested oral glucose tolerance test (OGTT) one week later after stroke. The impaired glucose regulation ( IGR ) and diabetes patients called the abnormal glucose metabolism group ,compare related indicators and make multivariate Logistic regression analysis .Results There were 68 patients(56.7%) with normal metabolism, 52 patients (43.3%) with abnormal glucose metabolism.Among them, 38 cases were IGR (31.7%), 14 cases were diabetes (11.7%).The rate of abnormality of impaired glucose metabolism in LAA subgroup(63.8%) was significantly higher than the other subgroups (27.3%-31.4%)(all P<0.05).There was no statistically significant difference between the other subgroups .Compared with normal glucose metabolism group, age, the rate of hyperlipidemian and family history of diabetes were significant higher in abnormal glucose metabolism group (P<0.05 -0.01).Multivariate logistic regression analysis showed that hyperlipidemia ( OR=1.671,95%CI:1.208 -2.311,P=0.012), family history of diabetes (OR =1.421,95%CI:1.114 -1.813,P=0.042) and LAA(OR=2.825,95%CI:1.706-4.674,P=0.023) were independent risk factors of new diagnosed abnormal glucose metabolism in ischemic stroke .Conclusion There is a high prevalence of new diagnosed abnormal glucose metabolism in ischemic stroke .Hyperlipidemia , family history of diabetes and LAA are independent risk factors of it .